Synapse - T-cell depleted (TCD) hematopoietic stem cell transplantation (HCT) for adult patients with acute myelogenous leukemia (AML) In first and second remission: Long-term disease free survival (DFS) with a significantly reduced risk of graft-versus-host disease (GvHD)

T-cell depleted (TCD) hematopoietic stem cell transplantation (HCT) for adult patients with acute myelogenous leukemia (AML) In first and second remission: Long-term disease free survival (DFS) with a significantly reduced risk of graft-versus-host disease (GvHD) Meeting Abstract

Authors:	Ceberio, I.; Hilden, P.; Devlin, S. M.; Maloy, M.; Goldberg, J. D.; Perales, M. A.; Barker, J. N.; Castro-Malaspina, H.; Koehne, G.; Ponce, D. M.; Sauter, C. S.; van den Brink, M. R. M.; Young, J. W.; O'Reilly, R. J.; Giralt, S.; Jakubowski, A. A.; Papadopoulos, E. B.
Abstract Title:	T-cell depleted (TCD) hematopoietic stem cell transplantation (HCT) for adult patients with acute myelogenous leukemia (AML) In first and second remission: Long-term disease free survival (DFS) with a significantly reduced risk of graft-versus-host disease (GvHD)
Meeting Title:	55th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	122
Issue:	21
Meeting Dates:	2013 Dec 7-10
Meeting Location:	New Orleans, LA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2013-11-15
Language:	English
ACCESSION:	WOS:000331385007151
PROVIDER:	wos
DOI:	10.1182/blood.V122.21.3387.3387
Notes:	Meeting Abstract: 3387 -- Source: Wos